期刊文献+

甲状腺功能正常桥本甲状腺炎患者血清ENO1Ab水平与轻度认知障碍的关联性分析 被引量:2

Analysis of the relationship between serum ENO1Ab level and mild cognitive impairment in Hashimoto's thyroiditis patients with normal thyroid function
下载PDF
导出
摘要 目的分析甲状腺功能正常桥本甲状腺炎(HT)患者血清α-烯醇化酶抗体(ENO1Ab)水平与轻度认知障碍(MCI)的关联性。方法招募2022年2月至2023年2月徐州医科大学附属医院收治的甲状腺功能正常的HT患者98例,根据简易精神状态评估量表(MMSE)评分将其分为认知功能正常组(55例,27分≤MMSE评分≤30分)和MCI组(43例,21分≤MMSE评分<27分)。比较两组甲状腺功能指标及血清ENO1Ab水平,通过多因素logistic回归分析HT患者发生MCI的影响因素。采用受试者工作特征(ROC)曲线分析评价ENO1Ab对HT患者发生MCI的诊断效能。结果MCI组年龄、甲状腺过氧化物酶抗体(TPOAb)、ENO1Ab水平均高于认知功能正常组,受教育程度低于认知功能正常组,差异均有统计学意义(P<0.05)。相关性分析结果显示,MMSE评分与年龄、TPOAb、ENO1Ab呈负相关(P<0.05)。多因素logistic回归分析结果显示,较大的年龄,以及较高的TPOAb、ENO1Ab水平是促进HT患者发生MCI的独立危险因素(P<0.05)。ROC曲线分析结果显示,ENO1Ab具有诊断HT合并MCI的应用价值[AUC(95%CI)=0.745(0.648~0.843),P=0.001],其最佳截断值为9.455 ng/ml,对应的灵敏度为62.80%,特异度为76.40%。结论甲状腺功能正常HT患者MCI的发生风险与ENO1Ab水平呈正关联,应引起临床医师的关注。 Objective To investigate the relationship between serum alpha-enolase antibody(ENO1Ab)level and mild cognitive impairment(MCI)in Hashimoto's thyroiditis(HT)patients with normal thyroid function.Methods Ninety-eight HT patients with normal thyroid function who were admitted to the Affiliated Hospital of Xuzhou Medical University from February 2022 to February 2023 were recruited and divided into a normal cognitive function group(55 cases,27 points≤Mini-Mental State Examination(MMSE)scores≤30 points)and an MCI group(43 cases,21 points≤MMSE scores<27 points)according to the MMSE score.The thyroid function indexes and serum ENO1Ab levels were compared between the two groups.The influencing factors of MCI in the HT patients were analyzed by multivariate logistic regression.Receiver operating characteristic(ROC)curve analysis was used to evaluate the diagnostic efficacy of ENO1Ab for MCI in the HT patients.Results The age,thyroid peroxidase antibody(TPOAb)and ENO1Ab levels in the MCI group were higher than those in the normal cognitive function group,and the education level in the MCI group was lower than that in the normal cognitive function group,and the differences were statistically significant(P<0.05).The results of correlation analysis showed that MMSE score was negatively correlated with age,TPOAb and ENO1Ab(P<0.05).The results of multivariate logistic regression analysis showed that older age and higher levels of TPOAb and ENO1Ab were independent risk factors for promoting MCI in the HT patients(P<0.05).The results of ROC curve analysis showed that ENO1Ab had application value in diagnosing HT complicated with MCI[AUC(95%CI)=0.745(0.648-0.843),P=0.001],and its optimal cut-off value was 9.455 ng/ml.The corresponding sensitivity and specificity were 62.80% and 76.40%,respectively.Conclusion The occurrence of MCI in the HT patients with normal thyroid function is positively correlated with ENO1Ab level,which should be paid attention to by clinicians.
作者 王岳 孙娟 何苗苗 于洪恩 李小霜 张珍华 WANG Yue;SUN Juan;HE Miao-miao(The First Clinical Medical College of Xuzhou Medical University,Jiangsu 221000,China)
出处 《中国临床新医学》 2023年第9期946-950,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 桥本甲状腺炎 轻度认知障碍 α-烯醇化酶抗体 甲状腺过氧化物酶抗体(TPOAb) Hashimoto's thyroiditis(HT) Mild cognitive impairment(MCI) Alpha-enolase antibody(ENO1Ab) Thyroid peroxidase antibody(TPOAb)
  • 相关文献

参考文献8

二级参考文献32

  • 1第二届颈椎病专题座谈会纪要[J].中华外科杂志,1993,31(8):472-476. 被引量:2441
  • 2罗鸣,罗卓荆,师晓宸,袁志,初晨宇.椎动脉型颈椎病患者的记忆障碍特征调查[J].中国临床康复,2005,9(12):35-37. 被引量:3
  • 3张军,孙树椿,于栋,张淳,武震.交感神经及其递质在椎动脉型颈椎病中的调控机制[J].中国骨伤,2005,18(7):413-415. 被引量:41
  • 4日常生活能力量表(ADL)[J].中国微侵袭神经外科杂志,2006,11(11):516-516. 被引量:65
  • 5The National Academy of Clinical Biochemistry (NACB).Laboratory Medicine Practice Guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid ,2003,13 : 3- 126.
  • 6The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006,16 : 109-141.
  • 7Teng WP, Shah ZY, Teng XC, et al. Effect of iodine intake on thyroid disease in China. N Engl J Med, 2006, 354:2783-2793.
  • 8Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA, 1995, 273:808-812.
  • 9邢家骝.131I治疗甲状腺功能亢进.邢家骝.131I治疗甲状腺疾病.北京:人民卫生出版社,2002.152-196.
  • 10中华医学会核医学分会.甲状腺疾病的131I治疗.中华医学会.临床技术操作规范·核医学分册.北京:人民军医出版社,2004.175-177.

共引文献230

同被引文献29

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部